AbCellera discovers antibodies and develops them with pharmaceutical, biotechnology and nonprofit partners. It last closed at $9.69 on Nov 20, down 7.45% on the day. The next earnings report for ABCL is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, ABCL reported EPS of -$0.13 on revenue of $10.6M, with revenue up 18.8% from a year ago. Over its last 8 reports the stock moved an average of 5.5% the session after earnings. Over the last 12 months ABCL insiders bought $3.5M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is ABCL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ABCL.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ABCLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ABCL · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 22% below its 20 day and 27% below its 50 day average. It is 23% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot S1 at $9.43, and the nearest resistance the Pivot at $9.84.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 9.0%/day
Key levels
$15.0252 week high+55.0%
$12.3050 day average+26.9%
$11.82Swing high (Sep 3)+22.0%
$11.7920 day average+21.7%
$10.49100 day average+8.3%
$10.11Pivot R1+4.3%
$9.84Pivot+1.5%
$9.69Last close
$9.43Pivot S1−2.7%
$7.42200 day average−23.4%
$5.02Swing low (Jun 9)−48.2%
$2.7552 week low−71.6%
Indicators
RSI (14)
33.92
Weak, oversold below 30
Neutral
MACD
-0.47
Below its signal line
Bearish
Stochastic
6.3
Near the bottom of its range
Oversold
ADX (14)
14.8
No clear trend
Williams %R
-96.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-200.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.4%
Change over 10 sessions
Bearish
ATR (14)
$0.87
Typical daily range, 9.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 16.8%/day
Key levels
$15.0252 week high+55.0%
$12.3050 day average+26.9%
$11.82Swing high (Sep 3)+22.0%
$11.7920 day average+21.7%
$10.49100 day average+8.3%
$10.11Pivot R1+4.3%
$9.84Pivot+1.5%
$9.69Last close
$9.43Pivot S1−2.7%
$7.42200 day average−23.4%
$5.02Swing low (Jun 9)−48.2%
$2.7552 week low−71.6%
Indicators
RSI (14)
50.33
Middle of its range
Neutral
MACD
1.43
Below its signal line
Bearish
Stochastic
38.5
Middle of its range
Neutral
ADX (14)
41.9
Strong uptrend
Williams %R
-98.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-5.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−11.0%
Change over 10 sessions
Bearish
ATR (14)
$1.63
Typical daily range, 16.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for ABCL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ABCL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ABCL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ABCLHow many large options trades hit ABCL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ABCL in the last 90 days.
From SEC Form 4 filings by ABCL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABCL is in one of them and how their past ABCL trades turned out.
AbCellera is a biotechnology company based in Vancouver, British Columbia, Canada. It uses its antibody discovery and development platform to find antibodies that partners can turn into drug candidates. Its partners include pharmaceutical companies, biotechnology companies, and nonprofit and government organizations. AbCellera receives upfront payments for technology access and discovery research, and it may also receive milestone payments and royalties if partner drugs advance or sell.